Status:
COMPLETED
Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral Rhinosinusitis
Lead Sponsor:
Bitop AG
Conditions:
Acute Rhinosinusitis
Eligibility:
All Genders
6+ years
Brief Summary
The goal of this non interventional study is to investigate the efficacy, tolerability and safety of the newly developed Ectoin Nasal Douche END01. Within the study, END01 will be used as concomitant ...
Detailed Description
The current non-interventional study aims to investigate the efficacy, tolerability and safety of a decongestant Xylometazoline-containing nasal spray in comparison to use of a decongestant Xylometazo...
Eligibility Criteria
Inclusion
- patients with acute viral rhinosinusitis
- presence of common cold symptoms
Exclusion
- contraindications in accordance with instructions for use
- acute bacterial rhinosinusitis
- chronic rhinosinusitis
Key Trial Info
Start Date :
November 27 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03480100
Start Date
November 27 2017
End Date
May 31 2018
Last Update
July 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
bitop AG
Witten, North Rhine-Westphalia, Germany, 58453